Simulations Plus

Home

Products

Resources

Support

Investors

Contact

	Oral absorption and pharmacokinectic simulation software
	*New Release: Version 2.4.0!* Software for the estimation of ADMET properties combined with advanced model-building capabilities
	Multi-purpose software for chemical data visualization and analysis
	Simulation software for in vitro dissolution experiments

GlaxoSmithKline Renews and Expands Global License for Simulations Plus Soft

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ:SLP - News), a leading provider of software for pharmaceut...

Simulations Plus Reports Second Quarter and Six Months FY2008 Financial Res

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq:SLP - News), a leading provider of simulation and modeling...

New Release!
Simulations Plus releases ADMET Predictor 2.4.0
Simulations Plus, Inc. has released a major upgrade to ADMET Predictor software for pharmaceutical research and development. New features include:

1) Brand new set of 10 predictive models covering metabolism in human.
- Quantitative prediction of Km and Vmax (kinetic Michaelis-Menten constants) for hydroxylation reaction by human CYP P450 enzymes: 1A2, 2C19, 2C9, 2D6, and 3A4.
- A result of collaboration with Enslein Research, Inc.

2) Program modularization. ADMET Predictor is now split into four independent modules:
- Physico-chemical and Biopharmaceutical Module

- Toxicity Module

- Metabolism Module

- ADMET Modeler and Descriptors Module